`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`
`
`
`IN RE: AFLIBERCEPT PATENT
`LITIGATION
`
`
`THIS DOCUMENT RELATES TO
`ALL CASES
`
`
` MDL NO. 1:24-MD-3103-TSK
`
`ORDER REGARDING LIAISON COUNSEL
`On April 26, 2024, the Court directed the parties to nominate
`
`liaison counsel. ECF No. 24. Upon review of the parties’
`recommendations and supporting materials, the Court selects the
`following to serve as liaison counsel:
` Regeneron Pharmaceuticals, Inc.: David I. Berl of Williams &
`Connolly LLP;
`
` Amgen Inc.: John R. Labbe of Marshall, Gerstein & Borun LLP;
`
` Celltrion, Inc.: Robert Cerwinski of Gemini Law LLP;
`
` Formycon AG: Louis E. Fogel, Ph.D., of Fish & Richardson P.C.;
`
` Mylan Pharmaceuticals Inc. and Biocon Biologics Inc.: William
`A. Rakoczy of Rakoczy Molino Mazzochi Siwik LLP; and
`
` Samsung Bioepis, Co., Ltd.: Raymond N. Nimrod, of Quinn
`Emanuel Urquhart & Sullivan, LLP.
`At this stage, liaison counsel will be responsible for
`coordinating administrative matters for their respective party.
`The Court may only be contacted, in writing, by liaison counsel.
`See Fed. Judicial Ctr., Manual for Complex Litigation (4th ed.,
`2004).
`
`
`
`Case 1:24-cv-00039-TSK Document 164 Filed 05/21/24 Page 2 of 2 PageID #: 356
`
`It is so ORDERED.
`The Clerk is DIRECTED to transmit copies of this Order to
`counsel of record.
`
`DATED: May 21, 2024
`
`
`
`
`
`
`
`
`
`
`
`
`
`____________________________
`THOMAS S. KLEEH, CHIEF JUDGE
`NORTHERN DISTRICT OF WEST VIRGINIA
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`